Nutriband (NASDAQ:NTRB) Trading Down 4.5% - Here's What Happened

Key Points

• Nutriband Inc. shares dropped by 4.5% on Monday, closing at $6.85, after trading as low as $6.66, with a total volume of 103,950 shares.
• The company reported a quarterly loss of $0.12 EPS, slightly beating expectations, but had a revenue of only $0.67 million, missing the consensus estimate.
• 19.70% of Nutriband's stock is held by institutional investors, with notable recent acquisitions made by Consolidated Portfolio Review Corp and US Bancorp DE.

Nutriband Inc. (NASDAQ:NTRB - Get Free Report) shares fell 4.5% during trading on Monday . The stock traded as low as $6.66 and last traded at $6.85. 103,950 shares were traded during trading, a decline of 45% from the average session volume of 190,536 shares. The stock had previously closed at $7.17.

Nutriband Trading Down 4.5%

The company has a 50 day simple moving average of $7.92 and a 200 day simple moving average of $6.86. The company has a current ratio of 3.71, a quick ratio of 3.48 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $76.38 million, a PE ratio of -7.61 and a beta of 1.13.

Nutriband (NASDAQ:NTRB - Get Free Report) last posted its quarterly earnings data on Friday, May 30th. The company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.01. The firm had revenue of $0.67 million during the quarter, compared to the consensus estimate of $0.71 million. Nutriband had a negative return on equity of 68.25% and a negative net margin of 415.93%. Analysts predict that Nutriband Inc. will post -0.6 earnings per share for the current fiscal year.

Institutional Trading of Nutriband

Several institutional investors and hedge funds have recently added to or reduced their stakes in NTRB. Consolidated Portfolio Review Corp acquired a new stake in shares of Nutriband in the 2nd quarter valued at approximately $81,000. US Bancorp DE acquired a new stake in shares of Nutriband in the 1st quarter valued at approximately $29,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Nutriband by 7.5% in the 4th quarter. Geode Capital Management LLC now owns 62,435 shares of the company's stock valued at $294,000 after buying an additional 4,372 shares during the period. 19.70% of the stock is owned by hedge funds and other institutional investors.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.